| 1 |
What is the main advantage of using nanomaterials in electrochemical sensors for medical diagnostics?
|
3. They enhance sensitivity and surface area for detection |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following nanomaterials is frequently mentioned as enhancing sensor conductivity?
|
2. Gold nanoparticles |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why are carbon-based nanomaterials such as carbon nanotubes (CNTs) useful in electrochemical sensors?
|
3. They improve electron transfer and mechanical strength |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
What is one challenge in integrating nanotechnology with electrochemical sensors for medical use?
|
3. Issues in reproducibility and standardization |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
Which technique is commonly used to enhance the signal in nanotechnology-based electrochemical sensors?
|
2. Enzyme labeling |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is biocompatibility crucial in designing electrochemical sensors for medical diagnostics?
|
2. To prevent rejection or toxicity in biological systems |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
How do label-free electrochemical sensors differ from labeled ones?
|
3. They do not rely on additional reagents or markers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What is one promising application of nanotech-based electrochemical sensors?
|
2. Early detection of disease biomarkers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
Which of the following factors most directly affects the sensor's detection limit?
|
2. Nanomaterial surface-to-volume ratio |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What is one of the primary goals of using digital sensing technologies in cancer care?
|
3. Enable earlier and more personalized diagnosis |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
Which type of sensor is often used to monitor physical activity in cancer patients?
|
3. Accelerometers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Why are patient-reported outcomes important in digital cancer care systems?
|
3. They provide subjective data complementing sensor metrics |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What is one major advantage of real-time digital sensing in cancer treatment?
|
3. Rapid detection of deterioration in patient condition |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
Which of the following is a key barrier to implementing digital sensing in routine oncology practice?
|
3. Limited digital literacy among patients and providers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
Which stakeholders are considered central to the adoption of digital cancer care platforms?
|
2. Patients and healthcare providers |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
Digital sensing systems collect which combination of data types for cancer care optimization?
|
2. Sensor metrics and patient-reported outcomes |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
How do digital sensors contribute to improving the quality of life in cancer patients?
|
3. By enabling symptom tracking and early intervention |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What does the article suggest about the future direction of digital sensing in cancer care?
|
3. It holds promise for widespread personalized care |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
Based on the diagram, which of the following would most likely result in a false signal output in an electrochemical sensor for medical diagnostics?
|
1. Using a transducer made of non-conductive materials |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on the image, which of the following scenarios best demonstrates the advantage of using emerging digital platforms in cancer diagnostics?
|
3. A portable chip-based sensor detects protein biomarkers from a blood sample within minutes |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|